Show simple item record

dc.contributor.authorWeibel, Daniel
dc.contributor.authorSturkenboom, Miriam
dc.contributor.authorBlack, Steven
dc.contributor.authorde Ridder, Maria
dc.contributor.authorDodd, Caitlin
dc.contributor.authorBonhoeffer, Jan
dc.contributor.authorVanrolleghem, Ann
dc.contributor.authorvan der Maas, Nicoline
dc.contributor.authorLammers, Gert Jan
dc.contributor.authorOvereem, Sebastiaan
dc.contributor.authorGentile, Angela
dc.contributor.authorGiglio, Norberto
dc.contributor.authorCastellano, Vanesa
dc.contributor.authorKwong, Jeffrey C
dc.contributor.authorMurray, Brian J
dc.contributor.authorCauch-Dudek, Karen
dc.contributor.authorJuhasz, Diana
dc.contributor.authorCampitelli, Michael
dc.contributor.authorDatta, Alexandre N
dc.contributor.authorKallweit, Ulf
dc.contributor.authorHuang, Wan-Ting
dc.contributor.authorHuang, Yu-Shu
dc.contributor.authorHsu, Chung-Yao
dc.contributor.authorChen, Hsi-Chung
dc.contributor.authorGiner-Soriano, Maria
dc.contributor.authorMorros, Rosa
dc.contributor.authorGaig, Carles
dc.contributor.authorTió, Ester
dc.contributor.authorPerez-Vilar, Silvia
dc.contributor.authorDiez-Domingo, Javier
dc.contributor.authorPuertas, Francisco Javier
dc.contributor.authorSvenson, Lawrence W
dc.contributor.authorMahmud, Salaheddin M
dc.contributor.authorCarleton, Bruce
dc.contributor.authorNaus, Monika
dc.contributor.authorArnheim-Dahlström, Lisen
dc.contributor.authorPedersen, Lars
dc.contributor.authorDeStefano, Frank
dc.contributor.authorShimabukuro, Tom T
dc.date.accessioned2018-11-19T09:34:17Z
dc.date.available2018-11-19T09:34:17Z
dc.date.issued2018
dc.identifier.citationNarcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment. 2018, 36 (41):6202-6211 Vaccineen
dc.identifier.issn1873-2518
dc.identifier.pmid30122647
dc.identifier.doi10.1016/j.vaccine.2018.08.008
dc.identifier.urihttp://hdl.handle.net/10029/622224
dc.description.abstractIn 2010, a safety signal was detected for narcolepsy following vaccination with Pandemrix, an AS03-adjuvanted monovalent pandemic H1N1 influenza (pH1N1) vaccine. To further assess a possible association and inform policy on future use of adjuvants, we conducted a multi-country study of narcolepsy and adjuvanted pH1N1 vaccines.
dc.language.isoenen
dc.rightsArchived with thanks to Vaccineen
dc.titleNarcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment.en
dc.typeArticleen
dc.identifier.journalVaccine 2018; 36(41):6202-11en
html.description.abstractIn 2010, a safety signal was detected for narcolepsy following vaccination with Pandemrix, an AS03-adjuvanted monovalent pandemic H1N1 influenza (pH1N1) vaccine. To further assess a possible association and inform policy on future use of adjuvants, we conducted a multi-country study of narcolepsy and adjuvanted pH1N1 vaccines.


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record